<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37369861</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>4729</StartPage><EndPage>4743</EndPage><MedlinePgn>4729-4743</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-023-11838-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting the upper and lower motor neurons, which can lead to death from respiratory failure within 3-5&#xa0;years after the onset of this disease. Nowadays, no drug can effectively slow down the progression of this disease. High-calorie therapy, an emerging complementary alternative treatment, has been reported in studies to prolong the survival time of patients, prevent muscle atrophy and provide a better prognosis. However, no systematic review and meta-analysis were performed to summarize the evidence of this therapy. This meta-analysis comprehensively evaluates the effectiveness and safety of high-calorie therapy for treating ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched the electronic databases from inception to 1 April 2023: PubMed, Embase, Web of Science, Cochrane Library, Scopus, Ovid/Medline, and ProQuest. Randomized controlled trials (RCTs) that met the inclusion criteria were performed by meta-analysis. All statistical analyses were performed in STATA software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of six eligible RCTs were included in this meta-analysis, involving 370 ALS patients. The meta-analyses showed that high-calorie therapy had superiority in improving body weight (SMD&#x2009;=&#x2009;1, 95% CI 0.36, 1.65) and BMI (SMD&#x2009;=&#x2009;0.83, 95% CI 0.02, 1.63). With respect to safety, there was no difference between the high-calorie therapy and the control group regarding the number of adverse events (RR&#x2009;=&#x2009;3.61, 95% CI 0.08, 162.49). However, ALSFRS-R scores (SMD&#x2009;=&#x2009;0.34, 95% CI -&#x2009;0.4, 1.08), survival rate (RR&#x2009;=&#x2009;1.23, 95% CI 0.98, 1.55), and lipid profile (LDL: SMD&#x2009;=&#x2009;0.21, 95% CI -&#x2009;0.33, 0.75; HDL: SMD&#x2009;=&#x2009;0.17, 95% CI -&#x2009;0.37, 0.71; TC: SMD&#x2009;=&#x2009;0.21, 95% CI -&#x2009;0.33, 0.75), CRP (SMD&#x2009;=&#x2009;0.85, 95% CI -&#x2009;1.37, 3.06) showed no significant difference compared to the control groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">High-calorie therapy is effective in gaining weight and BMI with few side effects. However, no significant superiority was detected in ALSFRS-R scores, survival time, lipid profile, and CRP indicator. The overall quality of the included studies is high, and the results have some credibility, but future corroboration by high-quality RCTs is also expected.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhu</LastName><ForeName>Qiaochu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Orthopedics, Hubei University of Chinese Medicine, Wuhan, 430065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Dandan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430061, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Institute of Traditional Chinese Medicine, Wuhan, 430061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430061, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Institute of Traditional Chinese Medicine, Wuhan, 430061, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of International Culture Education, Chodang University, Muan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Acupuncture and Orthopedics, Hubei University of Chinese Medicine, Wuhan, 430065, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>First Clinical Medical College, Hubei University of Chinese Medicine, Wuhan, 430065, China. zhoujing@hbhtcm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China. zhoujing@hbhtcm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430061, China. zhoujing@hbhtcm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Institute of Traditional Chinese Medicine, Wuhan, 430061, China. zhoujing@hbhtcm.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>First Clinical Medical College, Hubei University of Chinese Medicine, Wuhan, 430065, China. zhaoyan@hbhtcm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China. zhaoyan@hbhtcm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, 430061, China. zhaoyan@hbhtcm.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tuina and Rehabilitation Medicine, Hubei Institute of Traditional Chinese Medicine, Wuhan, 430061, China. zhaoyan@hbhtcm.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022BCA055</GrantID><Agency>Department of Science and Technology, Hubei Provincial People's Government</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008055">Lipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008055" MajorTopicYN="N">Lipids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">High-calorie therapy</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Nutrition</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList><CoiStatement>All authors declared that they have no competing or conflicting interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37369861</ArticleId><ArticleId IdType="pmc">PMC10511594</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-11838-4</ArticleId><ArticleId IdType="pii">10.1007/s00415-023-11838-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang B, Chen R, Tang L, Liu R, Yang Y, Yang Y, Liu X, Ye S, Zhan S, Fan D. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry. 2015;86(10):1075&#x2013;1081. doi: 10.1136/jnnp-2015-310471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310471</ArticleId><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Riluzole and edaravone: a tale of two amyotrophic lateral sclerosis drugs. Med Res Rev. 2019;39(2):733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Pioro EP, Udeh BL, Lapin BR, Katzan IL. A cost-effectiveness framework for amyotrophic lateral sclerosis applied to riluzole. Value Health. 2020;23(12):1543&#x2013;1551. doi: 10.1016/j.jval.2020.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2020.06.012</ArticleId><ArticleId IdType="pubmed">33248509</ArticleId></ArticleIdList></Reference><Reference><Citation>Achtert K, Kerkemeyer L. The economic burden of amyotrophic lateral sclerosis: a systematic review. Eur J Health Econ. 2021;22(8):1151&#x2013;1166. doi: 10.1007/s10198-021-01328-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-021-01328-7</ArticleId><ArticleId IdType="pubmed">34143346</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Gonzalez L, Martinez A. Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert Opin Investig Drugs. 2023;32(2):141&#x2013;160. doi: 10.1080/13543784.2023.2178416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2023.2178416</ArticleId><ArticleId IdType="pubmed">36762798</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayemendy P, Marin B, Labrunie A, Boirie Y, Walrand S, Achamrah N, Coeffier M, Preux PM, Lautrette G, Desport JC, Couratier P, Jesus P. Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects. J Neurol Sci. 2021;420:117257. doi: 10.1016/j.jns.2020.117257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117257</ArticleId><ArticleId IdType="pubmed">33290920</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, Preux PM, Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang LP, Fan DS. Diets for patients with amyotrophic lateral sclerosis: pay attention to nutritional intervention. Chin Med J (Engl) 2017;130(15):1765&#x2013;1767. doi: 10.4103/0366-6999.211549.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.211549</ArticleId><ArticleId IdType="pmc">PMC5547825</ArticleId><ArticleId IdType="pubmed">28748846</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, Gonzalez DAJ, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA. 2004;101(30):11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7&#x2013;8):533&#x2013;536. doi: 10.3109/21678421.2013.823999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.823999</ArticleId><ArticleId IdType="pubmed">23944684</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Kuhnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011;258(4):613&#x2013;617. doi: 10.1007/s00415-010-5805-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5805-z</ArticleId><ArticleId IdType="pubmed">21128082</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi: 10.1136/bmj.n160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n160</ArticleId><ArticleId IdType="pmc">PMC8005925</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313(16):1657&#x2013;1665. doi: 10.1001/jama.2015.3656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.3656</ArticleId><ArticleId IdType="pubmed">25919529</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schunemann HJ, Edejer T, Varonen H, Vist GE, Williams JJ, Zaza S. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. doi: 10.1136/bmj.328.7454.1490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.328.7454.1490</ArticleId><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Doenz J, Kandler K, Dreyhaupt J, Tumani H, Witzel S, Schuster J, Ludolph AC. Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study. J Neurol Neurosurg Psychiatry. 2022;93(3):298&#x2013;302. doi: 10.1136/jnnp-2021-328331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-328331</ArticleId><ArticleId IdType="pubmed">35022317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Meyer T, Petri S, Hermann A, Emmer A, Grosskreutz J, Grehl T, Zeller D, Boentert M, Schrank B, Prudlo J, Winkler AS, Gorbulev S, Roselli F, Schuster J, Dupuis L. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann Neurol. 2020;87(2):206&#x2013;216. doi: 10.1002/ana.25661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar T, Hanes GP, Ladha SS, Heiman-Patterson T, Katz J, Lou JS, Mahoney K, Grasso D, Lawson R, Yu H, Cudkowicz M. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383(9934):2065&#x2013;2072. doi: 10.1016/S0140-6736(14)60222-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva LB, Mourao LF, Silva AA, Lima NM, Almeida SR, Franca MJ, Nucci A, Amaya-Farfan J. Effect of nutritional supplementation with milk whey proteins in amyotrophic lateral sclerosis patients. Arq Neuropsiquiatr. 2010;68(2):263&#x2013;268. doi: 10.1590/s0004-282x2010000200021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0004-282x2010000200021</ArticleId><ArticleId IdType="pubmed">20464297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Yuan T, Yang H, Zhou X, Cao J. Effect of complete high-caloric nutrition on the nutritional status and survival rate of amyotrophic lateral sclerosis patients after gastrostomy. Am J Transl Res. 2022;14(11):7842&#x2013;7851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9730112</ArticleId><ArticleId IdType="pubmed">36505314</ArticleId></ArticleIdList></Reference><Reference><Citation>Janse VMM, van Eijk R, van der Burgh HK, Tan H, Westeneng HJ, van Es MA, Veldink JH, van den Berg LH. Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2020;91(8):867&#x2013;875. doi: 10.1136/jnnp-2020-322909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-322909</ArticleId><ArticleId IdType="pubmed">32576612</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkki H. Motor neuron disease: high-calorie diet might delay amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10(4):181. doi: 10.1038/nrneurol.2014.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.40</ArticleId><ArticleId IdType="pubmed">24614518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg J, Bottman L, Arra EJ, Selkirk SM, Kozlowski F. Nutrition management methods effective in increasing weight, survival time and functional status in ALS patients: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(1&#x2013;2):7&#x2013;11. doi: 10.1080/21678421.2017.1360355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1360355</ArticleId><ArticleId IdType="pubmed">28799809</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M, Katikireddi SV, Sowden A, Thomson H. Lack of transparency in reporting narrative synthesis of quantitative data: a methodological assessment of systematic reviews. J Clin Epidemiol. 2019;105:1&#x2013;9. doi: 10.1016/j.jclinepi.2018.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.08.019</ArticleId><ArticleId IdType="pmc">PMC6327109</ArticleId><ArticleId IdType="pubmed">30196129</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia K, Wang Y, Zhang L, Tang L, Zhang G, Huang T, Huang N, Fan D. Dietary-derived essential nutrients and amyotrophic lateral sclerosis: a two-sample mendelian randomization study. Nutrients. 2022 doi: 10.3390/nu14050920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14050920</ArticleId><ArticleId IdType="pmc">PMC8912818</ArticleId><ArticleId IdType="pubmed">35267896</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico E, Grosso G, Nieves JW, Zanghi A, Factor-Litvak P, Mitsumoto H. Metabolic abnormalities, dietary risk factors and nutritional management in amyotrophic lateral sclerosis. Nutrients. 2021 doi: 10.3390/nu13072273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072273</ArticleId><ArticleId IdType="pmc">PMC8308334</ArticleId><ArticleId IdType="pubmed">34209133</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B, Jin Y, Kim SH, Park Y. Association between macronutrient intake and amyotrophic lateral sclerosis prognosis. Nutr Neurosci. 2020;23(1):8&#x2013;15. doi: 10.1080/1028415X.2018.1466459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2018.1466459</ArticleId><ArticleId IdType="pubmed">29690822</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10(1):75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Ozdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol. 2016;12(11):651&#x2013;661. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135(4):489&#x2013;509. doi: 10.1007/s00401-018-1835-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Carling D, Sanders MJ, Woods A. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 2008;32(Suppl 4):S55&#x2013;S59. doi: 10.1038/ijo.2008.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2008.124</ArticleId><ArticleId IdType="pubmed">18719600</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8(10):774&#x2013;785. doi: 10.1038/nrm2249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2249</ArticleId><ArticleId IdType="pubmed">17712357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yenari MA, Liu J, Zheng Z, Vexler ZS, Lee JE, Giffard RG. Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann N Y Acad Sci. 2005;1053:74&#x2013;83. doi: 10.1196/annals.1344.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1344.007</ArticleId><ArticleId IdType="pubmed">16179510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Sui Y, Gao W, Cai B, Fan D. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. J Int Med Res. 2015;43(1):67&#x2013;79. doi: 10.1177/0300060514554725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060514554725</ArticleId><ArticleId IdType="pubmed">25534414</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald TS, McCombe PA, Woodruff TM, Lee JD. The potential interplay between energy metabolism and innate complement activation in amyotrophic lateral sclerosis. FASEB J. 2020;34(6):7225&#x2013;7233. doi: 10.1096/fj.201901781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201901781</ArticleId><ArticleId IdType="pubmed">32307753</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>